EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Circadian Modulators as Molecular Targets in Cancer—A Review

Anna Wolniakowska iD, Joanna Roszak iD, Zuzanna Sobańska iD, Edyta Reszka iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262411779 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna Wolniakowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Alternative Methods for Toxicity Assessment, Nofer Institute of Occupational Medicine, Św. Teresy 8, 91-348 Łódź, Poland. Hauptthemen laut MEDLINE: Neoplasms, Circadian Clocks, Circadian Rhythm, Antineoplastic Agents. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center in Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disruptions in the circadian clock and their link with cancer constitute a growing area of research, as evidenced by the steadily increasing number of articles on the topic. While the genes associated with circadian rhythms are relatively well characterized, the complexity of their regulation remains an important direction for study. It has been demonstrated that the interplay between genes, their expression products and external factors, such as environmental pollutants and human behavioral patterns, can lead to pathological changes, including metabolic diseases and cancer. Investigation of circadian cycle deregulations can not only provide a better understanding of carcinogenicity mechanisms and risk assessment but also create possibilities to identify new chemotherapeutics targeted at neoplastic cells. REV-ERBs and RORs are two groups of circadian clock-related nuclear factors that are examined regarding their interactions with small-molecule modulators of the circadian clock. These can act as either receptor agonists or inverse agonists, depending on the specific characteristics of a particular cancer. This review therefore summarizes and systematizes existing knowledge regarding the effectiveness of circadian modulators as chemotherapy agents, with the aim of indicating further directions for research in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCircadian ClocksCircadian RhythmAntineoplastic AgentsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

cancercircadian clocksmall-molecule modulators

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Center for Alternative Methods for Toxicity Assessment, Nofer Institute of Occupational Medicine, Św. Teresy 8, 91-348 Łódź, Poland.
  • Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Łódź, Poland.

ORCID-Profile: Anna Wolniakowska, Joanna Roszak, Zuzanna Sobańska, Edyta Reszka

Förderung

  • National Science Center in Poland

Zitieren

APA

Wolniakowska, A., Roszak, J., Sobańska, Z., & Reszka, E. (2025). The Circadian Modulators as Molecular Targets in Cancer—A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411779

Vancouver

Wolniakowska A, Roszak J, Sobańska Z, Reszka E. The Circadian Modulators as Molecular Targets in Cancer—A Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411779

BibTeX
@article{Wolniakowska2025,
  author = {Wolniakowska, Anna and Roszak, Joanna and Sobańska, Zuzanna and Reszka, Edyta},
  title = {The Circadian Modulators as Molecular Targets in Cancer—A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262411779}
}
Kostenlos starten →